Baidu
map

Neurology:早期复发性TIA的特征、频率和结局

2020-07-30 MedSci原创 MedSci原创

该研究是第一个评估早期复发性TIA患者长期结局的研究。该研究的观察结果支持及时发现和治疗早期复发性TIA的重要性,以减少不良临床结局的早期和长期风险。

近日,神经病学领域权威杂志Neurology上发表了一篇研究文章,该研究旨在评估早期复发性短暂性脑缺血(TIA)的频率、临床和病因学特征、短期和长期结局。

该前瞻性观察性队列研究纳入了所有转诊至急诊科(ED)并由血管神经科医生诊断的TIA患者。在24小时内进行了快速评估和最佳二级预防。该研究的主要终点为卒中和综合结局,包括卒中、急性冠状动脉综合征和3、12个月时血管死亡,部分患者为60个月;次要结局是TIA复发、脑出血、新发房颤和其他原因导致的死亡。研究人员还评估了TIA与随后卒中病因之间的一致性。

从2010年8月至2017年12月,该研究总共招募了1035例患者(822例TIA,213例TIA复发患者,占21%)。内囊预警综合征和大动脉粥样硬化与早期TIA复发之间的关系最为密切。在每次随访中,早期复发性TIA亚组卒中的风险更高,大多数卒中发作发生在TIA后48小时内。早期复发TIA亚组中,伴有病变、构音障碍和白质软化的TIA是3个月和12个月卒中发生的独立预测因子。TIA和随后的卒中病因学表现具有一致性。ABCD3评分>6预测在整个随访过程中卒中复发的风险更高。

由此可见,该研究是第一个评估早期复发性TIA患者长期结局的研究。该研究的观察结果支持及时发现和治疗早期复发性TIA的重要性,以减少不良临床结局的早期和长期风险。

原始出处:

Matteo Foschi,.et al.Prospective observational cohort study of early recurrent TIA: Features, frequency, and outcome.Neurology.2020.https://n.neurology.org/content/early/2020/07/29/WNL.0000000000010317.abstract

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1078223, encodeId=0e2910e822395, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fe55613728, createdName=ms2000000371747721, createdTime=Wed Dec 08 21:54:31 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1909830, encodeId=96221909830d6, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42518, encryptionId=8f1f42518d8, topicName=复发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Jun 22 12:04:07 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001092, encodeId=dc4a200109242, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Dec 20 13:04:07 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756999, encodeId=801e1e569994a, content=<a href='/topic/show?id=929f5936375' target=_blank style='color:#2F92EE;'>#早期复发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59363, encryptionId=929f5936375, topicName=早期复发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5bd37287806, createdName=124985dbm18(暂无昵称), createdTime=Fri Jun 25 06:04:07 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888087, encodeId=866988808e87, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200826/39ffc551fb8f47a28b631c5ba2936b7f/67d8dfcf90a24598b1033041c7e7b5a4.jpg, createdBy=3ff14827973, createdName=1378958079, createdTime=Thu Sep 24 22:21:28 CST 2020, time=2020-09-24, status=1, ipAttribution=)]
    2021-12-08 ms2000000371747721

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1078223, encodeId=0e2910e822395, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fe55613728, createdName=ms2000000371747721, createdTime=Wed Dec 08 21:54:31 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1909830, encodeId=96221909830d6, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42518, encryptionId=8f1f42518d8, topicName=复发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Jun 22 12:04:07 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001092, encodeId=dc4a200109242, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Dec 20 13:04:07 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756999, encodeId=801e1e569994a, content=<a href='/topic/show?id=929f5936375' target=_blank style='color:#2F92EE;'>#早期复发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59363, encryptionId=929f5936375, topicName=早期复发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5bd37287806, createdName=124985dbm18(暂无昵称), createdTime=Fri Jun 25 06:04:07 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888087, encodeId=866988808e87, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200826/39ffc551fb8f47a28b631c5ba2936b7f/67d8dfcf90a24598b1033041c7e7b5a4.jpg, createdBy=3ff14827973, createdName=1378958079, createdTime=Thu Sep 24 22:21:28 CST 2020, time=2020-09-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1078223, encodeId=0e2910e822395, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fe55613728, createdName=ms2000000371747721, createdTime=Wed Dec 08 21:54:31 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1909830, encodeId=96221909830d6, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42518, encryptionId=8f1f42518d8, topicName=复发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Jun 22 12:04:07 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001092, encodeId=dc4a200109242, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Dec 20 13:04:07 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756999, encodeId=801e1e569994a, content=<a href='/topic/show?id=929f5936375' target=_blank style='color:#2F92EE;'>#早期复发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59363, encryptionId=929f5936375, topicName=早期复发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5bd37287806, createdName=124985dbm18(暂无昵称), createdTime=Fri Jun 25 06:04:07 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888087, encodeId=866988808e87, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200826/39ffc551fb8f47a28b631c5ba2936b7f/67d8dfcf90a24598b1033041c7e7b5a4.jpg, createdBy=3ff14827973, createdName=1378958079, createdTime=Thu Sep 24 22:21:28 CST 2020, time=2020-09-24, status=1, ipAttribution=)]
    2020-12-20 yinhl1978
  4. [GetPortalCommentsPageByObjectIdResponse(id=1078223, encodeId=0e2910e822395, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fe55613728, createdName=ms2000000371747721, createdTime=Wed Dec 08 21:54:31 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1909830, encodeId=96221909830d6, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42518, encryptionId=8f1f42518d8, topicName=复发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Jun 22 12:04:07 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001092, encodeId=dc4a200109242, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Dec 20 13:04:07 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756999, encodeId=801e1e569994a, content=<a href='/topic/show?id=929f5936375' target=_blank style='color:#2F92EE;'>#早期复发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59363, encryptionId=929f5936375, topicName=早期复发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5bd37287806, createdName=124985dbm18(暂无昵称), createdTime=Fri Jun 25 06:04:07 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888087, encodeId=866988808e87, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200826/39ffc551fb8f47a28b631c5ba2936b7f/67d8dfcf90a24598b1033041c7e7b5a4.jpg, createdBy=3ff14827973, createdName=1378958079, createdTime=Thu Sep 24 22:21:28 CST 2020, time=2020-09-24, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1078223, encodeId=0e2910e822395, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fe55613728, createdName=ms2000000371747721, createdTime=Wed Dec 08 21:54:31 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1909830, encodeId=96221909830d6, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42518, encryptionId=8f1f42518d8, topicName=复发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Jun 22 12:04:07 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001092, encodeId=dc4a200109242, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Dec 20 13:04:07 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756999, encodeId=801e1e569994a, content=<a href='/topic/show?id=929f5936375' target=_blank style='color:#2F92EE;'>#早期复发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59363, encryptionId=929f5936375, topicName=早期复发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5bd37287806, createdName=124985dbm18(暂无昵称), createdTime=Fri Jun 25 06:04:07 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888087, encodeId=866988808e87, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200826/39ffc551fb8f47a28b631c5ba2936b7f/67d8dfcf90a24598b1033041c7e7b5a4.jpg, createdBy=3ff14827973, createdName=1378958079, createdTime=Thu Sep 24 22:21:28 CST 2020, time=2020-09-24, status=1, ipAttribution=)]
    2020-09-24 1378958079

    学习

    0

相关资讯

LANCET:男性每两月/女性每三月献血一次,对健康无影响

献血对人体健康到底有没有伤害?来看看奇点网对最新lancet的文献解析! 英国牛津大学和剑桥大学的研究人员对4.5万献血者随访2年的大型随机临床试验首次证实,就算超过相关规定进行更频繁的献血(男性提高到每8周一次,女性每12周一次)也不会对献血者的生活质量、身体活动以及认知功能产生明显影响,更不会发生重大不良事件。

突发性耳聋的药物治疗

当今社会,生活、工作节奏增快,可谓人人有压力,许多成年人长期处于精神高度紧张状态,所以时不时会听到身边的人喊:本来听力好好的,年纪轻轻的,怎么突然之间就聋了?!——这就是突发性耳聋。与多数疾病不同,突发性耳聋患者的主力是中青年人,所占比例超过了50%。

Mol Genet Genomic Med:非综合征听力损失1201名患者中常见耳聋基因变异分析

听力损伤是最常见的出生缺陷之一,影响的比例大约为每1000名新生儿中的1名。然而,到目前为止中国非综合征耳聋的分子病因仍旧未知。最近,有研究人员调查了陕西省非综合症耳聋患者中3个常见变异基因的突变情况,另外,陕西省的出生缺陷频率在中国最高。研究总共包括了1201名非综合症耳聋患者和300名健康个体。研究人员通过听力评估来对听力能力进行确定,并通过Sanger测序对3个主要的耳聋相关基因(GJB2,

Eur Arch Otorhinolaryngol: 体外人类上皮细胞中,MP 29-02对纤毛运动频率影响的研究

MP 29-02包含氟替卡松丙酸酯和盐酸氮卓斯汀成分,并且在季节性和常年性和变应性鼻炎治疗中作为鼻腔局部应用药物。尽管关于临床症状的减少和MP 29-02安全性方面有大量的数据可利用,而MP 29-02对纤毛运动频率(CBF)的影响仍旧没有相关数据。最近,有研究人员利用2.5%、5%、10%和20%的MP 29-02浓度溶液对14名健康的参与者进行了处理,之后将鼻纤毛上皮细胞利用相差显微镜实现可视

Stroke:结核性脑膜炎患者脑梗死的频率和影响

由此可见,脑梗塞使大部分TBM病例病情变得复杂。传统的血管危险因素是脑梗死的最重要的预测因素,未来的努力需要关注这些高风险的TBM患者,以降低发病率和死亡率。

Int J Impot Res:获得性早泄患者病因频率分析

尽管早泄(PE)是一种常见的男性性功能障碍,其病理学机制还没有完全的阐释。一些医学问题,比如阴茎勃起障碍、抑郁、焦虑、激素障碍和慢性前列腺炎也许在获得性PE的病因中具有作用。最近,有研究人员评估了这些病因在获得性PE患者中的频率情况。研究的时间为2016年5月和7月之间,共包括了53名获得性PE患者。患者的平均年龄为42.41±11.14 (22-60)。PE的平均持续时间为34.18±36.76

Baidu
map
Baidu
map
Baidu
map